Table 1.

Patient Characteristics

	Median (range)
Gender	19 male, 11 female
Age at diagnosis (years)	12 (0.5–20)
Age at time of study (years)	12.5 (8–21)
Cumulative anthracycline dose (mg/m2)	330.5 (75–492)
Time since completion of treatment (months)	32.6 (1.6–194)
Time since last anthracycline treatment (months)	47.7 (2.5–136)
Time from pre-treatment echo to study echo (months)	55.4 (8.3–167)
Cancer type, n (%)
Osteosarcoma/Ewing’s sarcoma	11 (37%)
AML	4 (13%)
ALL	5 (17%)
Lymphoma	7 (23%)
Wilms’ tumor	1 (3%)
Rhabdomyosarcoma or synovial sarcoma	2 (7%)
Radiation to chest (n)	4 (13%)
Previous bone marrow transplantation (n)	4 (13%)

ALL, acute lymphoblastic leukemia; AML, acute myeloblastic leukemia.